Sparsentan
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
Sparsentan - SGLT2 inhibitor combination therapy in trials of IgA nephropathy.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 11, 2026
Evaluating sparsentan for the treatment of focal segmental glomerulosclerosis.
Journal: Expert opinion on pharmacotherapy
Published: August 20, 2026
Angiotensin system modulation in focal segmental glomerulosclerosis: pharmacological basis and clinical implications.
Journal: Expert opinion on pharmacotherapy
Published: July 29, 2026
Sibeprenlimab (Voyxact) for primary immunoglobulin A nephropathy.
Journal: The Medical letter on drugs and therapeutics
Published: July 24, 2026
Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.
Journal: Canadian journal of physiology and pharmacology
Published: June 30, 2026
Recent Advances in the Management of IgA Nephropathy: From Supportive Care to Targeted Therapies.
Journal: Cureus
Published: June 21, 2026
New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases.
Journal: Kidney medicine
Published: May 21, 2026
Twelve-month real-world outcomes of sparsentan in a multicenter Spanish IgA nephropathy cohort.
Journal: Clinical kidney journal
Published: May 08, 2026
Review of the clinical, humanistic, and economic burden of focal segmental glomerulosclerosis.
Journal: The American journal of managed care
Published: May 08, 2026
Endothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management.
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Published: May 05, 2026
Predictors of response and long-term tolerability of sparsentan in a real-world IgA nephropathy cohort.
Journal: Clinical kidney journal
Published: May 04, 2026
Pharmacovigilance assessment of gout: a real-world study using the FAERS database.
Journal: Frontiers in pharmacology
Published: April 29, 2026
Last Updated: 11/08/2026